Wells Fargo Upgrades Charles River Labs (CRL) to Outperform on Major Sell-Off
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JPMorgan Upgrades Charles River Labs (CRL) to Overweight
December 13, 2012 7:26 AM ESTJPMorgan upgraded Charles River Labs (NYSE: CRL) from to Overweight with a price target of $42.00 (from $40.00).
NOTE: This is the second upgrade of CRL today and follows yesterday's 9% sell-off on 2013 guidance.
For an analyst ratings summary and ratings... More
Charles River Labs (CRL) Guides FY13 EPS Below Views
December 12, 2012 7:34 AM ESTCharles River Laboratories International, Inc. (NYSE: CRL) provided guidance for 2013 and reaffirmed guidance for 2012.
James C. Foster, Chairman, President and Chief Executive Officer, said, The actions we have taken in the last three years to enhance our in vivo biology portfolio, improve our operating efficiency, and forge stronger... More
